Search

Hien Thi Tran

Examiner (ID: 9609)

Most Active Art Unit
1764
Art Unit(s)
1764, 1312, 1801
Total Applications
1244
Issued Applications
852
Pending Applications
137
Abandoned Applications
255

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6985936 [patent_doc_number] => 20050155096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Hgc-1, a gene encoding a member of the olfactomedin-related protein family' [patent_app_type] => utility [patent_app_number] => 10/497890 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 27845 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20050155096.pdf [firstpage_image] =>[orig_patent_app_number] => 10497890 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/497890
hGC-1, a gene encoding a member of the olfactomedin-related protein family Dec 8, 2002 Issued
Array ( [id] => 6930791 [patent_doc_number] => 20050281825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Cell proliferation inhibitor containing anti-pept antibody' [patent_app_type] => utility [patent_app_number] => 10/497900 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5241 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281825.pdf [firstpage_image] =>[orig_patent_app_number] => 10497900 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/497900
Cell growth inhibitor containing anti-PepT antibody Dec 3, 2002 Issued
Array ( [id] => 7469041 [patent_doc_number] => 20040102393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of heat shock protein 90-alpha expression' [patent_app_type] => new [patent_app_number] => 10/302571 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20527 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102393.pdf [firstpage_image] =>[orig_patent_app_number] => 10302571 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/302571
Modulation of heat shock protein 90-alpha expression Nov 21, 2002 Abandoned
Array ( [id] => 6791585 [patent_doc_number] => 20030086929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Treatment of prostate cancer by inhibitors of ATP synthase' [patent_app_type] => new [patent_app_number] => 10/268881 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8381 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086929.pdf [firstpage_image] =>[orig_patent_app_number] => 10268881 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/268881
Treatment of prostate cancer by inhibitors of ATP synthase Oct 9, 2002 Abandoned
Array ( [id] => 6647128 [patent_doc_number] => 20030104443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'AFAP sequences, polypeptides, antibodies and methods' [patent_app_type] => new [patent_app_number] => 10/246354 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 33421 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104443.pdf [firstpage_image] =>[orig_patent_app_number] => 10246354 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/246354
AFAP sequences, polypeptides, antibodies and methods Sep 17, 2002 Abandoned
Array ( [id] => 6696726 [patent_doc_number] => 20030108920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Tumor suppressor-like proteins that bind IGFBP2' [patent_app_type] => new [patent_app_number] => 10/237566 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 43333 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108920.pdf [firstpage_image] =>[orig_patent_app_number] => 10237566 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/237566
Tumor suppressor-like proteins that bind IGFBP2 Sep 8, 2002 Abandoned
Array ( [id] => 7354826 [patent_doc_number] => 20040048791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Method for treating neoplastic cells using cycloprodigiosin or salt thereof' [patent_app_type] => new [patent_app_number] => 10/237588 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7513 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048791.pdf [firstpage_image] =>[orig_patent_app_number] => 10237588 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/237588
Method for treating neoplastic cells using cycloprodigiosin or salt thereof Sep 4, 2002 Abandoned
Array ( [id] => 6852280 [patent_doc_number] => 20030144483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes' [patent_app_type] => new [patent_app_number] => 10/229335 [patent_app_country] => US [patent_app_date] => 2002-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8846 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144483.pdf [firstpage_image] =>[orig_patent_app_number] => 10229335 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/229335
Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes Aug 25, 2002 Abandoned
Array ( [id] => 473132 [patent_doc_number] => 07230083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Anti-alphabeta3 humanized monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 10/223880 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 18005 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/230/07230083.pdf [firstpage_image] =>[orig_patent_app_number] => 10223880 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/223880
Anti-alphabeta3 humanized monoclonal antibodies Aug 19, 2002 Issued
Array ( [id] => 448674 [patent_doc_number] => 07250394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Treatment of glial tumors with glutamate antagonists' [patent_app_type] => utility [patent_app_number] => 10/225396 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10894 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250394.pdf [firstpage_image] =>[orig_patent_app_number] => 10225396 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/225396
Treatment of glial tumors with glutamate antagonists Aug 19, 2002 Issued
Array ( [id] => 6838457 [patent_doc_number] => 20030035797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof' [patent_app_type] => new [patent_app_number] => 10/218725 [patent_app_country] => US [patent_app_date] => 2002-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4970 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20030035797.pdf [firstpage_image] =>[orig_patent_app_number] => 10218725 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/218725
Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof Aug 12, 2002 Abandoned
10/110615 Colon-tumour-associated antigens Aug 7, 2002 Abandoned
Array ( [id] => 6654132 [patent_doc_number] => 20030077275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Recombinant anti-CD4 antibodies for human therapy' [patent_app_type] => new [patent_app_number] => 10/211357 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 22445 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077275.pdf [firstpage_image] =>[orig_patent_app_number] => 10211357 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/211357
Recombinant anti-CD4 antibodies for human therapy Aug 4, 2002 Issued
Array ( [id] => 6869512 [patent_doc_number] => 20030082201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Multivalent synthetic vaccine for cancer' [patent_app_type] => new [patent_app_number] => 10/211994 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 10834 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082201.pdf [firstpage_image] =>[orig_patent_app_number] => 10211994 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/211994
Multivalent synthetic vaccine for cancer Aug 1, 2002 Abandoned
Array ( [id] => 6735159 [patent_doc_number] => 20030012794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Kits comprising heat shock protein-antigenic molecule complexes' [patent_app_type] => new [patent_app_number] => 10/212031 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18915 [patent_no_of_claims] => 160 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20030012794.pdf [firstpage_image] =>[orig_patent_app_number] => 10212031 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/212031
Kits comprising heat shock protein-antigenic molecule complexes Aug 1, 2002 Abandoned
Array ( [id] => 875282 [patent_doc_number] => 07357915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Method of imaging cell death in vivo' [patent_app_type] => utility [patent_app_number] => 10/210986 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 9480 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/357/07357915.pdf [firstpage_image] =>[orig_patent_app_number] => 10210986 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/210986
Method of imaging cell death in vivo Aug 1, 2002 Issued
Array ( [id] => 6688322 [patent_doc_number] => 20030032047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Method for diagnosing selected adenocarcinomas' [patent_app_type] => new [patent_app_number] => 10/206508 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5699 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032047.pdf [firstpage_image] =>[orig_patent_app_number] => 10206508 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/206508
Method for diagnosing selected adenocarcinomas Jul 25, 2002 Abandoned
Array ( [id] => 6760788 [patent_doc_number] => 20030124149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Bioactive absorbable microparticles as therapeutic vaccines' [patent_app_type] => new [patent_app_number] => 10/191013 [patent_app_country] => US [patent_app_date] => 2002-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7893 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124149.pdf [firstpage_image] =>[orig_patent_app_number] => 10191013 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/191013
Bioactive absorbable microparticles as therapeutic vaccines Jul 7, 2002 Abandoned
Array ( [id] => 6846348 [patent_doc_number] => 20030165515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens' [patent_app_type] => new [patent_app_number] => 10/180563 [patent_app_country] => US [patent_app_date] => 2002-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14105 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165515.pdf [firstpage_image] =>[orig_patent_app_number] => 10180563 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/180563
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens Jun 24, 2002 Abandoned
Array ( [id] => 6402699 [patent_doc_number] => 20020182220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Use of heat shock protein 70 preparations in vaccination against cancer and infectious disease' [patent_app_type] => new [patent_app_number] => 10/180592 [patent_app_country] => US [patent_app_date] => 2002-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4198 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182220.pdf [firstpage_image] =>[orig_patent_app_number] => 10180592 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/180592
Use of heat shock protein 70 preparations in vaccination against cancer and infectious disease Jun 24, 2002 Abandoned
Menu